9999999997-16-019521.txt : 20160314 9999999997-16-019521.hdr.sgml : 20160314 20160314161153 ACCESSION NUMBER: 9999999997-16-019521 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160314 DATE AS OF CHANGE: 20160314 20160314 20160314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VBI VACCINES INC. CENTRAL INDEX KEY: 0000704159 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930589534 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-18188 FILM NUMBER: 161503947 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6178303031 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: PAULSON CAPITAL (DELAWARE) CORP. DATE OF NAME CHANGE: 20140326 FORMER COMPANY: FORMER CONFORMED NAME: PAULSON CAPITAL CORP DATE OF NAME CHANGE: 19920703 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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end